Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System.

Volume: 25, Issue: 21, Pages: 6548 - 6556
Published: Nov 1, 2021
Abstract
Immune checkpoint inhibitors (ICIs) are a major advance in cancer treatment, but their payment benefits are unclear, resulting in financial risk. In Taiwan, the National Health Insurance Administration (NHIA) has adapted risk-sharing mechanisms to cover ICIs by collecting and assessing real-world evidence, such as case registration data, to adjust benefit packages for each medication, increase payment benefits of ICIs, and enable national health...
Paper Details
Title
Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System.
Published Date
Nov 1, 2021
Journal
Volume
25
Issue
21
Pages
6548 - 6556
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.